共 50 条
- [43] Liver Toxicity of Initial Antiretroviral Drug Regimens Including Two Nucleoside Analogs Plus One Non-Nucleoside Analog or One Ritonavir-Boosted Protease Inhibitor in HIV/HCV-Coinfected Patients HIV CLINICAL TRIALS, 2012, 13 (02): : 61 - 69
- [46] Cost Assessment of Antiretroviral Drugs Used in the Treatment of Patients with HIV InfectionFocus on Non-Nucleoside Reverse Transcriptase Inhibitors Clinical Drug Investigation, 2002, 22 : 253 - 262